Healthcare charges in patients who transition from ocular hypertension to primary open-angle glaucoma based on ophthalmic coding data

被引:0
|
作者
Pasquale, Louis R. [2 ]
Walt, John G. [3 ]
Stern, Lee S. [1 ]
Wiederkehr, Daniel [1 ]
Malangone, Elisabetta [1 ]
Dolgitser, Margarita [1 ]
机构
[1] Analyt Int, New York, NY 10018 USA
[2] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Glaucoma Serv, Boston, MA USA
[3] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
关键词
healthcare economics; ocular hypertension; open-angle glaucoma; ophthalmology; BEAVER-DAM EYE; INTRAOCULAR-PRESSURE; UNITED-STATES; ECONOMIC BURDEN; BARBADOS EYE; DIRECT COSTS; CLAIMS DATA; PREVALENCE; POPULATION; MANAGEMENT;
D O I
10.1007/s12325-009-0073-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of this research was to assess the impact of transition from ocular hypertension (OHT) to primary open-angle glaucoma (POAG) on healthcare charges. A case-control group was identified using PharMetrics claims database (1998-2005). Cases (n=1055) had a transition from OHT to POAG based on International Classification of Disease, Ninth Edition coding (ICD-9=365.11). Controls (n=2110) retained an ICD-9 code for OHT (ICD-9=365.04) and were matched to cases (2:1) on gender, age, diagnosis year, and follow-up time post-diagnosis. The index date marked the transition for cases and a date of similar duration after OHT diagnosis for controls. Conditional logistic regression and multiple linear regression models determined the impact of transitioning on healthcare charges. Cases had significantly higher increases in ophthalmology-related charges ($797 vs. -$385, P < 0.0001) but similar total healthcare charges ($1689 vs. $1386, P=0.8277) from the year pre- to year post-index date when compared with controls. After adjusting for key covariates, cases were 1.56 times (95% CI: 1.33-1.82) more likely to have increased total charges and 5.26 times (95% CI: 4.27-6.47) more likely to have increased ophthalmology-related charges compared with controls. In multiple linear regression analyses, cases experienced $48 (55%) higher increases in ophthalmology-related charges from the year pre- to year post-index date compared with controls ($85 vs. $37, respectively; P < 0.0001). Patients with a transition from OHT to POAG based on ICD-9 coding had higher ophthalmology-related charges the year after transition compared with patients who retained a code for OHT. Prevention of this transition could result in healthcare resource savings.
引用
收藏
页码:947 / 958
页数:12
相关论文
共 50 条
  • [1] Healthcare charges in patients who transition from ocular hypertension to primary open-angle glaucoma based on ophthalmic coding data
    Louis R. Pasquale
    John G. Walt
    Lee S. Stern
    Daniel Wiederkehr
    Elisabetta Malangone
    Margarita Dolgitser
    Advances in Therapy, 2009, 26 : 947 - 958
  • [2] Health care charges for patients with ocular hypertension or primary open-angle glaucoma
    Pasquale, Louis R.
    Dolgitser, Margarita
    Wentzloff, Jeffrey N.
    Stern, Lee S.
    Doyle, John J.
    Chiang, Tina H.
    Walt, John G.
    OPHTHALMOLOGY, 2008, 115 (04) : 633 - 638
  • [3] Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost
    Gandolfi, SA
    Cimino, L
    OPHTHALMOLOGY, 2003, 110 (03) : 609 - 614
  • [4] ELECTROOCULOGRAM CHANGES IN PATIENTS WITH OCULAR HYPERTENSION AND PRIMARY OPEN-ANGLE GLAUCOMA
    MEHAFFEY, L
    HOLOPIGIAN, K
    SEIPLE, W
    DOCUMENTA OPHTHALMOLOGICA, 1993, 83 (02) : 103 - 110
  • [5] Pharmacotherapy Compliance in Patients with Ocular Hypertension or Primary Open-Angle Glaucoma
    Traverso, Carlo E.
    Walt, John G.
    Stern, Lee S.
    Dolgitser, Margarita
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 25 (01) : 77 - 82
  • [6] Functional parameters in patients with ocular hypertension and primary open-angle glaucoma
    Salomone, Mariella
    Verboschi, Francesca
    Fragiotta, Serena
    Valente, Stefano
    Domanico, Daniela
    Spadea, Leopoldo
    Vingolo, Enzo M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [7] Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension
    Kopczynski, C. C.
    Heah, T.
    DRUGS OF TODAY, 2018, 54 (08) : 467 - 478
  • [8] MICROCIRCULATION AND HEMODYNAMICS IN OCULAR HYPERTENSION AND PRIMARY OPEN-ANGLE GLAUCOMA
    ALEXEEV, BN
    SHMYREVA, VF
    MOSTOVOI, EN
    VESTNIK OFTALMOLOGII, 1986, (05) : 8 - 10
  • [9] Omidenepag isopropyl ophthalmic solution for open-angle glaucoma and ocular hypertension: an update
    Aihara, Makoto
    Aung, Tin
    Bacharach, Jason
    Cantor, Louis
    Kook, Michael
    Nakazawa, Toru
    Park, Ki Ho
    Lu, Da-Wen
    EXPERT REVIEW OF OPHTHALMOLOGY, 2021, 16 (04) : 243 - 250